New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
Page not found!
We’re sorry, we seem to have lost this page,
but we don’t want to lose you.
Please use the Search box in the upper right corner to locate what you're looking for. If you’re still having trouble finding the page, feel free to contact us. Or, you’re bound to find something of interest here:
GEN’s daily online biotech news coverage gives you the scoop on the latest business and research activities.
This column slices and dices the news and trends shaping the life sciences as well as the biotech industry.
GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends.
GEN hosts illustrative and instructional free webinars on tools and technologies used at various stages of drug discovery and development, from basic research through to biomanufacturing.
Whether you are searching for a DNA purification kit or outfitting a cGMP facility, GEN’s comprehensive new product database is your first and only stop.
In each print issue of Genetic Engineering & Biotechnology News, our Best of the Web columnist Taralyn Tan reviews websites of interest.
Get your listing of life science and biotech conferences, meetings, workshops, and more right here.